SCHEMBL4319153

SCHEMBL4319153

C[Si](C)(C)[C@@H](CC(=O)O)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
FOLH1 Q04609 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.39
CHRM1 P11229 1/20 0.35
AKR1A1 P14550 1/20 0.35
CHRM3 P20309 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35
HRH1 P35367 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
MAPT P10636 1/20 0.34
CPA1 P15085 2/20 0.34
ALOX15 P16050 1/20 0.34
CPB1 P15086 1/20 0.34
CPA3 P15088 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5003457 1.00 TDP1 (0.43) TDP1SMN1; SMN2FOLH1SLC22A6CHRM1
SCHEMBL654433 0.76 CHRM1 (0.36) TDP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL22555331 0.73 TDP1 (0.39) TDP1SMN1; SMN2FOLH1SLC22A6MAPT
SCHEMBL7899666 0.71 CPA1 (0.42) MAPTCPA1CPB1CPA3CPB2
SCHEMBL8970587 0.70 SLC22A6 (0.41) TDP1SMN1; SMN2SLC22A6ADRA1AMAPT
SCHEMBL7416626 0.69 GRIK1 (0.39)
SCHEMBL8617632 0.69 GRIK1 (0.39) MAPTCPA1
Tricarballylic Acid SCHEMBL34866 0.67 FOLH1 (0.65) TDP1SMN1; SMN2FOLH1SLC22A6CHRM1
Tricarballylic Acid SCHEMBL1821947 0.67 FOLH1 (0.65) TDP1SMN1; SMN2FOLH1SLC22A6CHRM1
SCHEMBL28832382 0.67 SLC22A6 (0.38) TDP1SMN1; SMN2SLC22A6HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed
EP-2084519-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING Los Alamos National Security, LLC (US) 2009-08-05 EP disclosed
WO-2008127291-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING LOS ALAMOS NATIONAL SECURITY, LLC (US) 2008-10-23 WO disclosed